Boehringer Ingelheim KG & Anor v Swingward Ltd
Defendants are entitled to a substantial proportion of their costs immediately, reflecting their success on the main issues, with the balance to be determined after the Austrian reference. Interim payments are appropriate given the circumstances and the unlikelihood of repayment being required.
- Parties
- Claimant/respondent: Boehringer Ingelheim KG; Claimant/respondent: Boehringer Ingelheim Pharma KG; Defendant/appellant: Swingward Limited; Defendant/appellant: Dowelhurst Limited; Claimant/respondent: Glaxo Group Limited; Claimant/respondent: The Wellcome Foundation Limited; Claimant/respondent: Smithkline Beecham plc; Claimant/respondent: Beecham Group plc; Claimant/respondent: Smithkline and French Laboratories Limited; Claimant/respondent: Eli Lilly and Company
- Jurisdiction
- England and Wales
- Judgment Date
- 31 July 2008
- Procedural Posture
- Civil Appeal (costs) / Post Judgment Costs Ruling
- Outcome
- Costs awarded to defendants with interim payments ordered; balance to be determined after Austrian reference.
- Legal Topics
- Costs, Patents, Interim Payments
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Boehringer Ingelheim KG
Claimant/respondent
Boehringer Ingelheim Pharma KG
Claimant/respondent
Swingward Limited
Defendant/appellant
Dowelhurst Limited
Defendant/appellant
Glaxo Group Limited
Claimant/respondent
The Wellcome Foundation Limited
Claimant/respondent
Smithkline Beecham plc
Claimant/respondent
Beecham Group plc
Claimant/respondent
Smithkline and French Laboratories Limited
Claimant/respondent
Eli Lilly and Company
Claimant/respondent
Procedural Posture
Civil Appeal (costs) / Post Judgment Costs Ruling
Legal Issues
- 1 Entitlement to costs pending outcome of Austrian reference
- 2 Proportion of costs to be awarded to defendants
- 3 Appropriateness of interim payments on costs
Ratio Decidendi
Defendants are entitled to a substantial proportion of their costs immediately, reflecting their success on the main issues, with the balance to be determined after the Austrian reference. Interim payments are appropriate given the circumstances and the unlikelihood of repayment being required.
Court Disposition
Costs awarded to defendants with interim payments ordered; balance to be determined after Austrian reference.
Orders
- Dowelhurst awarded 80% of its costs against Eli Lilly to date, with liberty to apply for the remaining 20% after the ECJ decision.
- Interim payment of £96,000 from Eli Lilly to defendants' solicitors.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment